Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system

European Journal of Cancer

Volumn 44, Issue 12, 2008, Pages 1744-1753

  Dalamaga, Maria ^a   Karmaniolas, Konstantinos ^b   Nikolaidou, Athina ^a   Chamberland, John ^c   Hsi, Alex ^c   Dionyssiou Asteriou, Amalia ^a   Mantzoros, Christos S ^c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NIMTS HOSPITAL   (Greece)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Adipokine; Adiponectin; Insulin like growth factor; Myelodysplastic syndrome; Obesity; Resistin

Indexed keywords

ADIPONECTIN; LEPTIN; RESISTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR SIZE; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; OBESITY; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

ADIPONECTIN; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; OBESITY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RESISTIN; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 48449094760     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.04.015     Document Type: Article

References (41)

1. Block M., Jacobson L.O., and Bethard W.F. Preleukemic acute human leukemia. J Am Med Assoc 152 (1953) 1018-1028
2. List A.F., and Doll D.F. The myelodysplastic syndromes. In: Lee G.R., Foerster J., Luken J., Paraskevas F., Greer J.P., Rodgers G.M., and Wintrobe M.M. (Eds). Wintrobe's clinical hematology (1999), Lippincott Williams & Wilkins, Baltimore 2320-2333
3. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51 (1982) 189-199
4. Aul C., Germing U., Gattermann N., and Minning H. Increasing incidence of myelodysplastic syndromes: real or fictitious?. Leuk Res 22 (1998) 93-100
5. Bennett J.M., and Komrokji R.S. The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment. Hematology 10 Suppl. 1 (2005) 258-269
6. Pasqualetti P., Festuccia V., Acitelli P., Collacciani A., Giusti A., and Casale R. Tobacco smoking and risk of haematological malignancies in adults: a case-control study. Br J Haematol 97 (1997) 659-662
7. Bjork J., Albin M., Mauritzson N., Stromberg U., Johansson B., and Hagmar L. Smoking and myelodysplastic syndromes. Epidemiology 11 (2000) 285-291
8. Dalamaga M., Petridou E., Cook F.E., and Trichopoulos D. Risk factors for myelodysplastic syndromes: a case-control study in Greece. Cancer Causes Control 13 (2002) 603-608
9. Ido M., Nagata C., Kawakami N., et al. A case-control study of myelodysplastic syndromes among Japanese men and women. Leuk Res 20 (1996) 727-731
10. Ross J.A., Parker E., Blair C.K., Cerhan J.R., and Folsom A.R. Body mass index and risk of leukemia in older women. Cancer Epidemiol Biomarkers Prev 13 (2004) 1810-1813
11. Wolk A., Gridley G., Svensson M., et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12 (2001) 13-21
12. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. New Engl J Med 348 (2003) 1625-1638
13. Mantzoros C.S., and Flier J.S. Insulin resistance: the clinical spectrum. Adv Endocrinol Metab 6 (1995) 193-232
14. Renehan A.G., Zwahlen M., Minder C., O'Dwyer S.T., Shalet S.M., and Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363 (2004) 1346-1353
15. Petridou E., Dessypris N., Spanos E., et al. Insulin-like growth factor-I and binding protein-3 in relation to childhood leukemia. Int J Cancer 80 (1999) 494-496
16. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 (2004) 2548-2556
17. Matarese G., Moschos S., and Mantzoros C.S. Leptin in immunology. J Immunol 174 (2005) 3137-3142
18. Mantzoros C., Petridou E., Dessypris N., et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89 (2004) 1102-1107
19. Dal Maso L., Augustin L.S., Karalis A., et al. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 89 (2004) 1160-1163
20. Goktas S., Yilmaz M.I., Caglar K., Sonmez A., Kilic S., and Bedir S. Prostate cancer and adiponectin. Urology 65 (2005) 1168-1172
21. Ishikawa M., Kitayama J., Kazama S., Hiramatsu T., Hatano K., and Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res 11 (2005) 466-472
22. Spyridopoulos T.N., Petridou E.T., Skalkidou A., Dessypris N., Chrousos G.P., and Mantzoros C.S. Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer 120 (2007) 1573-1578
23. Wei E.K., Giovannucci E., Fuchs C.S., Willett W.C., and Mantzoros C.S. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97 (2005) 1688-1694
24. Petridou E., Mantzoros C.S., Dessypris N., Dikalioti S.K., and Trichopoulos D. Adiponectin in relation to childhood myeloblastic leukaemia. Br J Cancer 94 (2006) 156-160
25. Yokota T., Oritani K., Takahashi I., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 (2000) 1723-1732
26. Lee J.H., Chan J.L., Yiannakouris N., et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 88 (2003) 4848-4856
27. Dalamaga M., Nikolaidou A., Karmaniolas K., et al. Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study. Oncology 73 (2007) 26-32
28. Greenberg P., Cox C., LeBeau M.M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
29. Mantzoros C.S., Trakatelli M., Gogas H., et al. Circulating adiponectin levels in relation to melanoma: a case-control study. Eur J Cancer 43 (2007) 1430-1436
30. Trujillo M.E., and Scherer P.E. Adiponectin-journey from an adipocyte secretory protein to biomarker of metabolic syndrome. J Intern Med 257 (2005) 167-175
31. Blüher M., Brennan A.M., Kelesidis T., et al. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care 30 (2007) 280-285
32. Larsson S.C., and Wolk A. Overweight and obesity and incidence of leukemia: A meta-analysis of cohort studies. Int J Cancer 122 (2008) 1418-1421
33. Khandwala H.M., McCutcheon I.E., Flyvbjerg A., and Friend K.E. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21 (2000) 215-244
34. Stifter G., Heiss S., Gastl G., Tzankov A., and Stauder R. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis. Eur J Haematol 75 (2005) 485-491
35. Flores-Figueroa E., Gutierrez-Espindola G., Montesinos J.J., Rana-Trejo R.M., and Mayani H. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome. Leuk Res 26 (2002) 677-686
36. Haugen F., and Drevon C.A. Activation of nuclear factor-kappa B by high molecular weight and globular adiponectin. Endocrinology 148 (2007) 5478-5486
37. Steppan C.M., Bailey S.T., Bhat S., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
38. Reilly M.P., Lehrke M., Wolfe M.L., Rohatgi A., Lazar M.A., and Rader D.J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111 (2005) 932-939
39. Zumkeller W. The insulin-like growth factor system in hematopoietic cells. Leuk Lymphoma 43 (2002) 487-491
40. Qi H., Xiao L., Lingyun W., et al. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis. Ann Hematol 85 (2006) 95-101
41. Tworoger S.S., Mantzoros C., and Hankinson S.E. Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels. Obesity 15 (2007) 2217-2224